Therapeutic Area | MeSH |
---|---|
respiratory tract diseases | D012140 |
cardiovascular diseases | D002318 |
Brand Name | Status | Last Update |
---|---|---|
bidil | New Drug Application | 2022-07-19 |
hydralazine | ANDA | 2022-02-15 |
hydralazine hcl | ANDA | 2019-04-30 |
hydralazine hydrochloride | ANDA | 2025-03-25 |
hydralazine hydrocloride | 2006-09-19 | |
isosorbide dinitrate and hydralazine hydrochloride | NDA authorized generic | 2024-07-01 |
Code | Description |
---|---|
J0360 | Injection, hydralazine hcl, up to 20 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 2 | 3 | 4 | 4 | 11 | 23 |
Heart failure | D006333 | EFO_0003144 | I50 | 1 | 3 | 3 | 6 | 3 | 15 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | 2 | — | 3 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | 1 | — | 2 |
Cardiogenic shock | D012770 | — | R57.0 | — | — | — | 1 | — | 1 |
Low cardiac output | D002303 | — | — | — | — | — | 1 | — | 1 |
Continuous ambulatory peritoneal dialysis | D010531 | — | — | — | — | — | 1 | — | 1 |
Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | — | 1 | — | 1 |
Mitral valve insufficiency | D008944 | — | — | — | — | — | 1 | — | 1 |
Systolic murmurs | D054160 | — | R01.1 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 1 | — | 2 | 5 |
Pregnancy-induced hypertension | D046110 | — | O13 | — | 1 | 1 | — | 2 | 4 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | 2 | — | — | 3 |
Uterine cervical neoplasms | D002583 | — | — | — | 1 | 2 | — | — | 3 |
Polycystic kidney diseases | D007690 | — | Q61.3 | 1 | — | 1 | — | — | 2 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 1 | — | — | 2 |
Syndrome | D013577 | — | — | — | 1 | 1 | — | — | 2 |
Hypercholesterolemia | D006937 | — | — | — | — | 1 | — | — | 1 |
Coronary disease | D003327 | — | — | — | — | 1 | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemorrhage | D006470 | MP_0001914 | R58 | — | 2 | — | — | 2 | 4 |
Cerebral hemorrhage | D002543 | — | — | — | 2 | — | — | 2 | 4 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | 2 | — | — | 1 | 3 |
Blood pressure | D001794 | EFO_0004325 | — | 1 | 1 | — | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | — | — | — | 2 |
Thrombectomy | D017131 | — | — | — | 2 | — | — | — | 2 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | — | — | 1 | 2 |
Eclampsia | D004461 | — | O15 | — | 1 | — | — | 1 | 2 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 1 | — | — | — | 1 |
Preleukemia | D011289 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pure autonomic failure | D054970 | — | — | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 1 | 1 |
Emergence delirium | D000071257 | — | — | — | — | — | — | 1 | 1 |
Intracranial hemorrhages | D020300 | EFO_0000551 | I62 | — | — | — | — | 1 | 1 |
Hypertensive crisis | D000096003 | — | I16 | — | — | — | — | 1 | 1 |
Proteinuria | D011507 | — | R80 | — | — | — | — | 1 | 1 |
Albuminuria | D000419 | EFO_0004285 | R80.9 | — | — | — | — | 1 | 1 |
Congenital heart defects | D006330 | — | Q24.9 | — | — | — | — | 1 | 1 |
Cerebrovascular disorders | D002561 | EFO_0003763 | I60-I69 | — | — | — | — | 1 | 1 |
Cerebral small vessel diseases | D059345 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Hydralazine |
INN | hydralazine |
Description | Hydralazine is the 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent. It has a role as an antihypertensive agent and a vasodilator agent. It is a member of phthalazines, an azaarene, an ortho-fused heteroarene and a member of hydrazines. |
Classification | Small molecule |
Drug class | antihypertensives (hydrazine-phthalazines); antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NNc1nncc2ccccc12 |
PDB | — |
CAS-ID | 86-54-4 |
RxCUI | — |
ChEMBL ID | CHEMBL276832 |
ChEBI ID | 5775 |
PubChem CID | 3637 |
DrugBank | DB01275 |
UNII ID | 26NAK24LS8 (ChemIDplus, GSRS) |